Lipella presents Phase 2a results for LP-10 at H.C. Wainwright conference

LIPELLA PHARMACEUTICALS INC.

Presented at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11, 2023.
Provided update on product pipeline and Phase 2a clinical trial results for drug candidate LP-10.
Presentation materials posted on company website at lipella.com.

item 7.01 item 9.01

LIPELLA PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001753926-23-001209

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.